Takeover talk swirls around Onyx; Pfizer sues Watson over generic Pristiq app;

@FiercePharma: Check out our special report: Pharma's Top 10 Marketing Settlements. Approx. $11 bn over 10 years. Special Report | Follow @FiercePharma

> Onyx Pharmaceuticals ($ONXX) is analysts' latest favorite takeover target, now that its experimental drug carfilzomib has drawn support from an FDA advisory panel and could be approved as soon as next month. Report

> Watson Pharmaceuticals ($WPI) asked FDA to approve its version of the Pfizer ($PFE) antidepressant Pristiq, and Pfizer sued to block the copycat drug. Report

> Spanish drugmaker Faes Farma says its earnings are threatened by payment delays from regional governments that are forcing pharmacies out of business. Report

> Japan's Daiichi Sankyo won FDA approval to start work at a new packaging plant in Pennsylvania, planning to take some outsourced operations back in-house. Report

> Russia's Veropharm posted first-quarter profits of 494.3 million roubles, or $14.83 million, a 46% increase, fueled by rising demand for prescription drugs. Report

> Cholesterol-fighting statin drugs work as well at preventing heart problems in women as they do in men. Report

Biotech News

 @FierceBiotech: Promising RA antibody data may help encourage new Ablynx partnership. Story | Follow @FierceBiotech

 @JohnCFierce: Does this controversy have legs? Maybe so. FDA review cites Amylin for withholding data on Bydureon app. Story | Follow @JohnCFierce

 @RyanMFierce: My interviews with eclinical CEOs at DIA 2012 about mobile, remote site monitoring, Microsoft partnerships: More | Follow @RyanMFierce

> R&D numbers point to a turnaround in pipeline productivity. Report

> Quintiles to offer new jobs to 100 axed Merck Serono staffers. Story

> Analysts conjure up images of a dream buyout deal for Onyx. Article

Medical Device News

@FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

@MarkHFierce: Another day, another deal closes. Covidien is now the proud new owner of Oridion Systems. The cost: $310M. Release | Follow @MarkHFierce

 @DamianFierce: Getting ahead of the pending device tax, Stryker has started its rolling layoffs, looking to cut 107 jobs. More | Follow @DamianFierce

> FDA OKs first glaucoma stent for cataract surgery. News

> User fee bill heads to White House. Story

> Following the U.K., FDA wants to take a hard look at hip implants. Article

Biotech Research News

> Scientists wield human stem cells to engineer blood-brain barrier structures. Story

> Cleveland BioLabs drug, chemo kill neuroblastomas in mice. Item

> U.K. researchers enhance tracking for stem cell injections. Article

> At long last, 2nd controversial look at bird flu virus finally published. More

Pharma Manufacturing News

> Sanofi plant problems result in vaccine shortage. News

> Novartis plant in Russia two years out. More

> Fake Viagra apparently sourced in China. Article

> Import alert lifted for AkzoNobel Mexico plant. Story

And Finally... The 2009 swine flu pandemic may have killed 15 times more people around the world than previously thought. Report